Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy aims to heal emotional scars after childhood brain injury

NCT ID NCT07303075

Symptom relief Sponsor: University of Nottingham Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a family-centred talking therapy (ACT) for young people aged 11-18 with acquired brain injury and their parents. Up to 6 families will receive 12 online therapy sessions. The goal is to see if the therapy is feasible and can improve emotional wellbeing, psychological flexibility, and participation in daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) - a type of talk therapy that helps people cope with difficult thoughts and feelings
What this could lead to
If this therapy works, it could offer a new way to help young brain injury survivors and their families manage emotional challenges and improve quality of life.
What could go wrong
This is a very small, early feasibility study with only 6 families, so results may not apply to everyone. The therapy is delivered online, which may not suit all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Both the CYP-ABI and parent participants must meet the inclusion criteria to be recruited to the study. CYP-ABI participant inclusion criteria include: * Aged 11 to 18 years at time of recruitment. * Living at home with parent/guardian. * Received treatment for an ABI. * Have sufficient cognitive ability to engage with therapy sessions. * Has capacity to provide verbal or written informed consent (aged 16 and above) or assent (aged 15 and younger). * Has the ability to speak sufficient English to understand and engage with the therapeutic and research materials * Consents for parent/guardian participant involvement in study. Parent participant inclusion criteria include: * Aged \> 18 at time of recruitment. There is no upper age limit. * Has the ability to speak sufficient English to understand and engage with the therapeutic and research materials * Has capacity to provide verbal or written informed consent for self and CYP participant. Exclusion Criteria: CYP-ABI and parent participant exclusion criteria include: • CYP or parent participants are currently accessing or have accessed structured psychological intervention within 6 months of study recruitment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acquired brain injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acquired brain injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.